{"organizations": [], "uuid": "f379c3502de3437ba389017f83e92a89a5b9fa86", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 1, "shares": 1, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180124.html", "section_title": "Archive News &amp; Video for Wednesday, 24 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-aurora-cannabis-cannimed-therapeut/brief-aurora-cannabis-cannimed-therapeutics-agree-to-terms-on-friendly-transaction-idUSFWN1PJ113", "country": "US", "domain_rank": 408, "title": "BRIEF-Aurora Cannabis, Cannimed Therapeutics Agree To Terms On Friendly Transaction", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-24T21:28:00.000+02:00", "replies_count": 0, "uuid": "f379c3502de3437ba389017f83e92a89a5b9fa86"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-aurora-cannabis-cannimed-therapeut/brief-aurora-cannabis-cannimed-therapeutics-agree-to-terms-on-friendly-transaction-idUSFWN1PJ113", "ord_in_thread": 0, "title": "BRIEF-Aurora Cannabis, Cannimed Therapeutics Agree To Terms On Friendly Transaction", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "aurora cannabis inc", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 24 (Reuters) - Aurora Cannabis Inc:\n* AURORA CANNABIS AND CANNIMED THERAPEUTICS AGREE TO TERMS ON FRIENDLY TRANSACTION\n* CANNIMED THERAPEUTICS INC - CANNIMED‘S BOARD AND SPECIAL COMMITTEE SUPPORT AURORA‘S OFFER OF SHARES AND CASH\n* CANNIMED THERAPEUTICS INC - ‍TOTAL CONSIDERATION FOR CANNIMED UNDER NEW OFFER IS APPROXIMATELY $1.1 BILLION BASED ON AURORA‘S IMPLIED SHARE PRICE OF $12.65​\n* CANNIMED THERAPEUTICS INC - TOTAL CONSIDERATION FOR CANNIMED UNDER NEW OFFER IS ABOUT $1.1 BILLION BASED ON AURORA‘S IMPLIED SHARE PRICE OF $12.65\n* CANNIMED THERAPEUTICS INC - UNDER NEW OFFER, CANNIMED SHAREHOLDERS MAY RECEIVE IN RESPECT OF EACH CANNIMED SHARE, 3.40 AURORA SHARES\n* CANNIMED THERAPEUTICS INC - ASSUMING MAXIMUM CASH ELECTIONS, EACH CANNIMED SHAREHOLDER WOULD RECEIVE $5.70 IN CASH AND 2.9493 AURORA SHARES\n* CANNIMED THERAPEUTICS INC - ‍IN CONNECTION WITH NEW OFFER, CANNIMED HAS ENTERED INTO A TERMINATION AGREEMENT WITH NEWSTRIKE RESOURCES​\n* CANNIMED THERAPEUTICS - ‍CANNIMED SHAREHOLDER MEETING ORIGINALLY SCHEDULED FOR JANUARY 23, 2018 AND ADJOURNED TO JANUARY 25, 2018 HAS BEEN CANCELLED​\n* CANNIMED THERAPEUTICS INC - NEW OFFER WOULD EQUATE TO $43.00 PER SHARE\n* CANNIMED THERAPEUTICS - ‍AURORA‘S NEW OFFER FOR CANNIMED TO CONTINUE TO BE SUPPORTED BY CERTAIN SHAREHOLDERS REPRESENTING 36% OF CO‘S SHARES\n* CANNIMED THERAPEUTICS INC - CO‘S TERMINATION OF AGREEMENT WITH NEWSTRIKE RESOURCES RESULTED IN PAYMENT OF A $9.5 MILLION BREAK FEE PAID TO NEWSTRIKE Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-24T21:28:00.000+02:00", "crawled": "2018-01-25T13:19:54.004+02:00", "highlightTitle": ""}